Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitCandida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysisEchinocandin resistance: an emerging clinical problem?Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.Elucidating drug resistance in human fungal pathogens.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsA risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.Candida parapsilosis, an emerging fungal pathogenEchinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience.Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011Antifungal drug resistance mechanisms.Human fungal pathogen Candida albicans in the postgenomic era: an overview.Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.Strategies to manage antifungal drug resistance.Caspofungin: when and how? The microbiologist's view.Antifungal susceptibility testing: a primer for clinicians.Invasive fungal infections in newborns and current management strategies.An Italian consensus for invasive candidiasis management (ITALIC).Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.Mechanisms of echinocandin antifungal drug resistance.Echinocandins: The Expanding Antifungal Armamentarium.The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.Correlation between biofilm formation and the hypoxic response in Candida parapsilosis.Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities.The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters.Identification of immunogenic proteins of Candida parapsilosis by serological proteome analysis.
P2860
Q21194915-03A58BDF-C9D2-46FE-841F-AE2C7E62478CQ28533912-2328460E-0513-4229-8F24-352FE171E236Q28544739-15BF9FF2-7701-4272-9B3F-8543F746F865Q30808061-E4091BE8-D661-4B32-85CF-60AF3ED2B953Q30826889-BD3A8A7A-A485-4465-B3DA-AF2599E2EC67Q30834974-F420B2B5-668C-48A4-BB79-36F126F1A8C3Q33876423-27FACAED-7E69-4911-A3BA-48852170520DQ34419351-96A3A983-C1E6-4120-8166-688E0F141152Q34529026-B9A548B0-5807-4F56-AB1A-882383EE0AD7Q34539213-1E1440A1-234A-468D-B72E-165880DE25FDQ34852747-096C8FE2-7EAD-4621-A378-57724D079A33Q35140020-F3DBCBEB-AF30-4A5A-915F-EBADD2A93A4DQ35363662-AB1BB660-239D-4AD9-BA61-3B00EEE01EA6Q35848669-EEC64851-2E88-4488-BAAA-F16F0258D4ACQ35880078-DDC993A8-A44E-4423-81A0-F86E6217F7C9Q36308069-9B4DE800-7324-4EB6-B9F1-16D9028CEFCBQ36667530-A9482A24-4393-4A7E-B41C-5E6A0E70955BQ37463223-619C78AD-A73C-4D09-BC2A-7E99388558FBQ37557700-C84C206E-4F3F-439C-823D-D35843A60C77Q37613000-2CEA685D-62C6-4EF2-A41C-F48CA92E5F90Q37759256-2B3654FD-27FD-4F5D-8D3E-924A276365F3Q37827872-19FBEFC4-811D-4EE7-9820-276FBF275518Q37888750-3643FB23-12D2-4D13-9DAC-AAF999F1314BQ38061087-64DD09AC-7505-4340-ADA2-0191C60BC92AQ38119554-8B04FE2E-598D-4106-9619-F6F1C10537CFQ38165883-99E3AC15-60C7-4C41-AD3E-2D410DB86D3FQ38254290-B031013C-07BD-4191-A20B-DA146B51C510Q38531765-D3B4F499-F460-4185-B82F-842E876443FFQ38550402-CECDA482-FC64-4393-B093-4A7EA4415D12Q38633102-1F652605-33A0-41A1-A29D-0DBA80C7C77FQ39375216-38C0AB30-897D-46FF-BDA1-BD04809F2BD8Q39686624-80F34A40-7B2A-4579-9D71-11E3510027D5Q41939680-ECDF3A63-C54B-431F-B9F6-F00E5E7E070AQ42035911-FBABF6A2-8870-4F55-A2B1-1DF90E31E600Q43145527-C1CA2B75-2BA4-4D79-B7DF-EC024ABE680EQ45852198-F34F9239-D1FE-4210-90DB-AD14A9AFA422Q45988034-83500035-8C2C-4ACE-9418-CCC230AFEE29Q46484431-278B0BB5-001A-4D47-A0AE-729B2341E4D2Q46682069-8568ED6F-B9D1-4029-8AA9-46D01B18A7A3Q46964249-6723A10D-96A5-4B94-A8A7-1AA5DB15AA93
P2860
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@en
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@nl
type
label
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@en
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@nl
prefLabel
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@en
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@nl
P2093
P1433
P1476
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
@en
P2093
Elizabeth Weekes
Graeme N Forrest
Jennifer K Johnson
P304
P356
10.1016/J.JINF.2007.10.014
P577
2007-12-21T00:00:00Z